Advertisement
Survey Series
Institutions
For Advertisers
|
|
||||
|
Perlegen Sciences' Recipe for Success
This biotech is fueling the fire of the International HapMap Project. What else does the company have cooking?
Email: Dana Wilkie - dwilkie@the-scientist.com The Scientist 2005, 19(11):38
|
||||
|
|
||||
|
Few people would envision a former Florida shrimp processor leading a multimillion-dollar Silicon Valley biotechnology company. But Brad Margus is no ordinary shrimp processor. Margus, the CEO of Perlegen Sciences in Mountain View, Calif., has two sons with ataxia-telangiectasia (A-T), a rare genetic disorder that causes neurological decline and early death, most often in the mid-20s. In 1993, when his toddler sons were diagnosed, Margus was a Harvard MBA heading up a south Florida company that sold shrimp to restaurants, cruise lines, and hotels.
|
|
|||||||||
|
|||||||||
|
